Full text
PDFPage 243
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Greene M. H., Boice J. D., Jr, Greer B. E., Blessing J. A., Dembo A. J. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med. 1982 Dec 2;307(23):1416–1421. doi: 10.1056/NEJM198212023072302. [DOI] [PubMed] [Google Scholar]
- Hilario R., Padre-Mendoza T., Albala M. M. Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation. Am J Med Sci. 1980 Sep-Oct;280(2):115–118. doi: 10.1097/00000441-198009000-00008. [DOI] [PubMed] [Google Scholar]
- Kyle R. A. Second malignancies associated with chemotherapeutic agents. Semin Oncol. 1982 Mar;9(1):131–142. [PubMed] [Google Scholar]
- Markman M., Howell S. B., Lucas W. E., Pfeifle C. E., Green M. R. Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity. J Clin Oncol. 1984 Dec;2(12):1321–1326. doi: 10.1200/JCO.1984.2.12.1321. [DOI] [PubMed] [Google Scholar]
- Pedersen-Bjergaard J., Nissen N. I., Sørensen H. M., Hou-Jensen K., Larsen M. S., Ernst P., Ersbøl J., Knudtzon S., Rose C. Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). Cancer. 1980 Jan 1;45(1):19–29. doi: 10.1002/1097-0142(19800101)45:1<19::aid-cncr2820450106>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Penn I. Second malignant neoplasms associated with immunosuppressive medications. Cancer. 1976 Feb;37(2 Suppl):1024–1032. doi: 10.1002/1097-0142(197602)37:2+<1024::aid-cncr2820370806>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Reimer R. R., Hoover R., Fraumeni J. F., Jr, Young R. C. Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med. 1977 Jul 28;297(4):177–181. doi: 10.1056/NEJM197707282970402. [DOI] [PubMed] [Google Scholar]
- Reimer R. R., Hoover R., Fraumeni J. F., Jr, Young R. C. Second primary neoplasms following ovarian cancer. J Natl Cancer Inst. 1978 Nov;61(5):1195–1197. doi: 10.1093/jnci/61.5.1195. [DOI] [PubMed] [Google Scholar]
- Rieche K. Carcinogenicity of antineoplastic agents in man. Cancer Treat Rev. 1984 Mar;11(1):39–67. doi: 10.1016/0305-7372(84)90016-1. [DOI] [PubMed] [Google Scholar]
- Tester W. J., Kinsella T. J., Waller B., Makuch R. W., Kelley P. A., Glatstein E., DeVita V. T. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. J Clin Oncol. 1984 Jul;2(7):762–769. doi: 10.1200/JCO.1984.2.7.762. [DOI] [PubMed] [Google Scholar]